Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bacterin International Holdings Inc's OsteoSelect DBM Putty Receives Approval For Spinal Fusion Applications


Tuesday, 23 Jul 2013 08:30am EDT 

Bacterin International Holdings Inc announced that it has obtained 510(k) approval to market OsteoSelect DBM Putty for use in spinal fusion procedures. OsteoSelect is a moldable bone graft substitute designed to withstand irrigation while exhibiting osteoinductive properties for improved bone regeneration. The cohesive nature of the product provides an advantage over other commercially available DBM putties which can readily wash away after placement in wet, surgical environments. 

Company Quote

2.6
-0.06 -2.26%
24 Dec 2014